Simple Blood Test Showing Promise in Lung Cancer Diagnosis
AUSTIN, Texas — Researchers on a self-described "fishing expedition" have discovered something unexpected — that a panel of serum metabolites could predict the presence of non-small cell lung cancer. The team compared blood from patients with a ...
Medscape - Fri, 07 Nov 2014 09:15

Lung cancer not only smoker's disease, says Middletown woman fighting ...
According to the American Lung Association's inaugural Women's Lung Health Barometer—a survey of over 1,000 American women ages 18+ that measures women's awareness, knowledge and perceptions about lung cancer—this disease is not even on ...
Middletown Press - Tue, 18 Nov 2014 16:30



The new era of immune checkpoint inhibitors
What got people excited was a lesser [compared with melanoma] but still significant response rate in non-small-cell lung cancer (NSCLC), as well as in bladder, and head and neck cancers,” says Louis Weiner, an immunotherapy expert and gastrointestinal ...
The Pharmaceutical Journal - Tue, 18 Nov 2014 08:21

Bind's Attempts To Remake Chemotherapy
This was a Phase II study in non-small-cell lung cancer patients with docetaxel, a widely used chemotherapy drug that could certainly use some targeted delivery. The results were mixed. Investors were clearly hoping for something better, but it could ...
Corante - Thu, 20 Nov 2014 04:55

Wall Street Overreacts To BIND Therapeutics Presentations (BIND)
Seeking Alpha - Thu, 20 Nov 2014 08:18

BIND Reports Positive Results from BIND-014 Polymeric Nanoparticle Phase 2 ...
AZoNano.com - Thu, 20 Nov 2014 04:11



FDA Approves Bevacizumab for Recurrent Ovarian Cancer
Bevacizumab, which was first approved in 2004, is indicated as a treatment in various settings for patients with metastatic colorectal cancer, metastatic non-squamous non-small cell lung cancer, recurrent glioblastoma, and metastatic renal cell carcinoma.
OncLive - Fri, 14 Nov 2014 11:14

Bevacizumab Now Cleared for Recurrent Ovarian Cancer
Clinical Oncology News - Mon, 17 Nov 2014 12:37

Another big win for Roche as Avastin nabs FDA ovarian cancer indication
BioPharma Dive - Mon, 17 Nov 2014 07:00

FDA Approves Genentech's Avastin (Bevacizumab) Plus Chemotherapy to Treat ...
PipelineReview.com (press release) - Fri, 14 Nov 2014 10:11



Pfizer, German firm to team up on potential cancer drug
Among the diseases that could see advances from the collaboration are non-small cell lung cancer, ovarian cancer and a rare skin cancer called metastatic Merkel cell carcinoma. Pfizer said the upfront payment to Merck would affect its year-end ...
TheDay.com - Tue, 18 Nov 2014 01:11

Pfizer strikes immuno-oncology pact with Merck
The Deal Pipeline - Mon, 17 Nov 2014 07:11

Merck KGaA Ties Up with Pfizer on Immuno-oncology Deal - Analyst Blog
Nasdaq - Tue, 18 Nov 2014 14:18

Merck KGaA, Pfizer Launch Up-to-$2.85B Cancer Immunotherapy Alliance
Genetic Engineering & Biotechnology News - Mon, 17 Nov 2014 06:48

Pfizer signs $2.85bn immuno-oncology alliance
PMLiVE - Mon, 17 Nov 2014 04:32

NY-ESO-1 (CTAG1B) expression in mesenchymal tumors
Expression was seen both in myxoid as well as round cell areas. In an additional 37.2% (16/43) of these neoadjuvantly treated tumors, weak staining in a small subset of the tumor cells was present; the remaining 20.9% (9/43) did not reveal any residual ...
Nature.com - Fri, 21 Nov 2014 04:37

Middletown woman fighting stage 4 lung cancer
According to the American Lung Association's inaugural Women's Lung Health Barometer—a survey of over 1,000 American women ages 18+ that measures women's awareness, knowledge and perceptions about lung cancer—this disease is not even on ...
Middletown Press - Tue, 18 Nov 2014 16:02


<-   1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014